Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Avai Bio (AVAI) Operating Expenses (2018 - 2024)

Avai Bio's Operating Expenses history spans 6 years, with the latest figure at $303432.0 for Q1 2024.

  • For Q1 2024, Operating Expenses rose 70.27% year-over-year to $303432.0; the TTM value through Mar 2024 reached $2.1 million, up 462.48%, while the annual FY2025 figure was $1.5 million, 27.6% down from the prior year.
  • Operating Expenses for Q1 2024 was $303432.0 at Avai Bio, down from $1.0 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $1.0 million in Q4 2023 and bottomed at $14506.0 in Q3 2020.
  • The 4-year median for Operating Expenses is $134282.5 (2022), against an average of $237657.0.
  • The largest annual shift saw Operating Expenses tumbled 53.2% in 2020 before it soared 1939.34% in 2023.
  • A 4-year view of Operating Expenses shows it stood at $70960.0 in 2020, then decreased by 29.94% to $49717.0 in 2022, then skyrocketed by 1939.34% to $1.0 million in 2023, then tumbled by 70.07% to $303432.0 in 2024.
  • Per Business Quant, the three most recent readings for AVAI's Operating Expenses are $303432.0 (Q1 2024), $1.0 million (Q4 2023), and $388328.0 (Q3 2023).